TruBridge (TBRG) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
31 Mar, 2026Executive summary
Filed 10-K after identifying non-cash, non-material out-of-period adjustments related to revenue recognition, capitalized software, and non-routine transactions, reflecting improved financial controls.
Engaged in a strategic review process to maximize shareholder value, considering options such as sale, joint venture, share repurchases, or organic investments; no formal guidance issued.
Strong pipeline growth, with recurring deals now over 70% of opportunities and recurring revenue comprising 94% of total revenue for both the quarter and year.
Operational improvements include global workforce transition, new leadership, offshoring strategy, and AI-driven initiatives across financial health, patient care, and customer service.
Bookings for Q4 were $19.8 million, up from $14.3 million year-over-year; full-year bookings $82.9 million, up slightly from $82.1 million.
Financial highlights
Q4 revenue was $87.2 million, flat with guidance; Adjusted EBITDA $19.2 million (22% margin), at high end of range, up from $17.9 million.
Full-year revenue reached $346.8 million, up 1.4% year-over-year; Adjusted EBITDA $68.7 million (19.8% margin), up from $55.9 million.
Q4 GAAP net loss was $5.5 million, compared to a $5.1 million loss in the prior year; full-year GAAP net income was $4.4 million versus a $20.9 million loss.
Q4 Non-GAAP net income was $11.4 million, up from $1.1 million; full-year Non-GAAP net income was $38.5 million, up from $4.6 million.
Cash and cash equivalents increased to $24.9 million at year-end from $12.3 million; net debt reduced to $139.8 million.
Outlook and guidance
No formal guidance due to ongoing strategic review and difficulty forecasting certain expenses, but anticipate modest revenue growth and ~200 basis points Adjusted EBITDA margin expansion in 2026.
Focus for 2026 includes targeted AI initiatives, technology modernization, and continued operational improvements.
Margin expansion expected from global workforce transition, cost optimization, and improved revenue mix.
Latest events from TruBridge
- Demand, bookings, and margins are rising as offshoring and automation drive operational gains.TBRG
Stephens 26th Annual Investment Conference | NASH2024 - Merger and executive compensation proposals both passed by majority stockholder vote.TBRG
EGM 2026 - Shareholders to vote on a premium cash merger with IKS; board and major holders support the deal.TBRG
Proxy filing - Shareholders to vote on cash merger at $26.25/share; board and major holders support the deal.TBRG
Proxy filing - Q1 2026 saw $86.3M revenue, rising non-GAAP net income, and a pending IKS acquisition.TBRG
Q1 2026 - TruBridge's acquisition by IKS Health targets improved healthcare access and operational stability.TBRG
Proxy filing - IKS Health to acquire TruBridge for $557M, creating a leading healthcare solutions platform.TBRG
Proxy filing - TruBridge will be acquired by IKS for $26.25 per share in cash, pending approvals.TBRG
Proxy filing - RCM growth and margin gains offset EHR declines as net loss widens and 2024 guidance is reaffirmed.TBRG
Q2 2024